James A. Zweifel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Abstract: The present invention is directed to amides of antibiotic A82846B (also known as chloroorienticin A), and of N.sup.4 -derivatives of A82846B. The present amide compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").
Type:
Grant
Filed:
May 1, 1997
Date of Patent:
July 6, 1999
Assignee:
Eli Lilly and Company
Inventors:
Robin David Grey Cooper, Michael John Rodriguez, Nancy June Snyder, Mark James Zweifel
© 2024 Justia
